You are 3 months into Ozempic. The weight is coming off, and you are pleased. Then one day, getting out of the shower, you catch sight of yourself and something looks different. Softer, or looser, or just not quite like you. Maybe sex feels drier than it used to. Maybe you have not said anything to anyone, because how would you even start that conversation.
You are not imagining it, and you are not alone. As more women in Singapore take Ozempic and similar medications, these very private changes, sometimes nicknamed Ozempic vulva, are coming up more often. Here is what is actually known, what is not, and what genuinely helps.
What is “Ozempic vulva”, and is it real?
Ozempic vulva is a media term, not a medical diagnosis, and there are no studies on it. It describes a looser or deflated look to the vulva, the outer genital area, that some women and clinicians have noticed after fast, significant weight loss.
The likely reason is simple. Rapid weight loss strips fat from all over the body, including the soft fat pads of the mons pubis and the labia majora, the outer lips. Skin does not always shrink back as fast as the fat underneath disappears, so the area can look deflated for a while. It is the same process behind “Ozempic face”, the sunken facial look that is well described with rapid weight loss. Applied to the vulva, though, it has not been studied, so we can tell you what women report, not what a trial has measured.

Can Ozempic cause vaginal dryness?
There is no evidence that Ozempic directly causes vaginal dryness, but the two can travel together. No study has tested it. What we can say is that vaginal dryness is very common in midlife for a different reason, and many women start these medications at exactly that stage of life.
That reason is menopause. As estrogen falls, the tissues of the vulva and vagina become thinner, drier, and less elastic, a cluster of changes doctors call the Genitourinary Syndrome of Menopause (GSM). In Singapore, about 1 in 5 midlife women report vaginal dryness (Logan et al., 2023). There is a theory that losing a lot of body fat quickly could nudge estrogen down further, because after menopause fat tissue becomes your main source of estrogen (Vieira-Potter et al., 2025). It is biologically plausible, but nobody has shown it happens with weight-loss drugs, so treat it as a maybe, not a fact.
Will Ozempic affect my sex life?
The honest answer is mixed, and you deserve both sides of it. For many women, losing weight improves sexual function. Obesity is linked to sexual difficulties in around half of women, and losing even 2 to 5% of body weight is associated with better sexual function scores (Bachani, 2021; Salari et al., 2023). Better energy, body image, and blood flow all play a part.
The other side is newer and still emerging. A growing clinical literature suggests GLP-1 medications may lower sexual desire in some women, possibly by acting on the brain’s reward pathways and by reducing blood flow to the genitals (Gelfand et al., 2025). There is also a single published case of a woman losing the ability to orgasm on a GLP-1, which resolved when she switched drugs (Visvabharathy et al., 2025). This is reports and theory, not proof, so we will not tell you it will happen. We will tell you it can, so you are not blindsided. If your desire or sex life changes in a way that bothers you, raise it with your prescriber.
Worried about the changes down there?
If sex has become uncomfortable, or your body feels different since starting the medication, an assessment can tell you what is hormones, what is muscle, and what helps.
Explore women’s health physiotherapy
Could it be something else?
New changes down there are not always about the medication, and naming the real cause is what gets you the right help. Several things overlap in midlife, and they need different treatments.
Dryness and discomfort may be genitourinary syndrome of menopause, which usually needs estrogen, and physiotherapy too, depending on the cause. Pain during sex may be that dryness, or it may be an overactive pelvic floor, where the muscles are too tight and tender rather than too loose. A looser appearance may be fat-pad volume loss, as above, which is cosmetic rather than medical. A heavy or bulging feeling is a different problem again, closer to prolapse. If your pelvic floor feels part of the picture, we cover this in Ozempic and your pelvic floor.
Telling these apart matters, because dry, estrogen-starved tissue and a tight, overactive muscle need different care, and sometimes both at once, estrogen to restore the tissue alongside downtraining for the muscle. This is why an assessment beats guessing. The same symptom can have opposite causes, and only an examination sorts out which one you are dealing with.
Not sure whether it is hormones or muscle?
If penetration hurts or your pelvic floor feels tight, our pelvic pain page explains how we assess and treat it.
Read about pelvic pain and vaginismus
What helps Ozempic vulva and vaginal dryness?
The most effective treatments are simple, and the strongest one needs a doctor. For day-to-day comfort, vaginal moisturisers used regularly and lubricants used during sex are the recommended first step (The Menopause Society, 2020; NICE, 2015). For dryness that is really down to menopause, the mainstay treatment is low-dose vaginal estrogen, a cream or pessary that restores the tissue. It works well, and it is prescription-only, so it comes from your GP or gynaecologist, not from us (Lethaby et al., 2016; NICE, 2015).
This is the honest dividing line. Estrogen deficiency is a medical problem with a medical treatment. A physiotherapist does not prescribe estrogen, and any blog that tells you physiotherapy alone fixes menopausal dryness is overselling. What we do is different, and it matters just as much.
How can a women’s health physiotherapist help?
A women’s health physiotherapist does far more than train muscles. We assess your pelvic floor to see whether pain or changed sensation is coming from muscles that have become too tight, and we treat that directly. But the pelvic floor is only part of it. We also work with the tissue itself and the nerves that supply it, which is where changes like vulvodynia and provoked vestibulodynia sit, using desensitisation, graded exposure, manual therapy, and dilator work to calm an oversensitive system and rebuild comfort.
Physiotherapy reduces pain during sex, and easing that pain is often the biggest step back to a comfortable, enjoyable sex life. Its direct effect on overall satisfaction is still being studied, but less pain is a real gain (Fernández-Pérez et al., 2023). We also coach you through moisturisers, lubricants, and, where your doctor has prescribed them, vaginal dilators, and we teach you how your body works so nothing feels like a mystery.
We work alongside your doctor, not instead of them. If you need estrogen, we will say so and help you get it. But the muscular, nerve, sensory, and confidence side of this is our home ground, and there is a great deal we can do. Either way, you are not meant to work this out alone, and you do not have to.
Frequently asked questions
Is “Ozempic vulva” permanent?
Often it settles as skin and tissue adjust over months, helped by weight stabilising and strength work. Where loose skin persists after very large weight loss, that is a cosmetic matter to discuss with a doctor, not a medical harm. Ozempic can affect muscle as well as skin and tissue, we cover how to protect it in Ozempic and muscle loss.
Does Ozempic cause vaginal dryness?
There is no evidence it directly does. Dryness in midlife is usually menopause-related, and the two often coincide. Moisturisers help daily comfort, and vaginal estrogen from your doctor treats the cause.
Will I lose interest in sex on Ozempic?
Most evidence points the other way, as weight loss tends to improve sexual function. A growing clinical literature and a single case report do describe reduced desire in some women, so tell your prescriber if something changes.
Can Ozempic stop my contraception working?
Possibly, and this one matters. Because these medications slow the stomach, they can reduce how well the contraceptive pill is absorbed, and this is clearest with tirzepatide (Mounjaro). Guidance advises using a backup method, such as condoms, for 4 weeks after starting and after each dose increase, or switching to a non-oral method. This is a decision for your doctor, so please raise it with your prescriber (British Menopause Society, 2025).
Can I take Ozempic with HRT?
For many women, yes, and it may even help. One study found postmenopausal women on hormone therapy plus semaglutide lost more weight than those on semaglutide alone (Hurtado et al., 2024). Whether HRT is right for you, and which type, is a medical decision to make with your doctor.
Do I need to see a doctor or a physiotherapist?
Often both. See your doctor for prescription treatments like vaginal estrogen or HRT, and a women’s health physiotherapist for the muscle, nerve, tissue, and comfort side. They work together.
Where can you get help in Singapore?

At our clinic in Katong, we talk about this every week, without embarrassment and without judgment. We will help you work out what is muscle, what is hormones, what is nerve or tissue related, and what simply needs time, and point you to the right treatment for each.
Your body is changing, and none of this means something has gone wrong with you. Weight loss is worth having, and the private parts of it deserve the same straightforward care as everything else.
This blog was written by Preet Singh, women’s health physiotherapist and founder of Embrace Physiotherapy. It is for information only and is not personal medical advice. Prescription treatments such as vaginal estrogen are outside physiotherapy scope and are decided with your doctor. Please seek individual assessment from a qualified healthcare professional.
References
- Bachani, P. (2021) ‘Association of weight loss with improved sexual function in females’, Cureus, 13(8), e16849. [Prospective cohort; lower-level evidence]
- British Menopause Society (2025) Use of incretin-based therapies in women using hormone replacement therapy (HRT). BMS Tool for Clinicians, April 2025.
- Fernández-Pérez, P. et al. (2023) ‘Effectiveness of physical therapy interventions in women with dyspareunia: a systematic review and meta-analysis’, BMC Women’s Health, 23, 387.
- Gelfand, S.T. et al. (2025) ‘Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don’t “see” it’, Obesity Pillars, 17(4), 100233.
- Hurtado, M.D. et al. (2024) ‘Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use’, Menopause, 31(4), pp. 266–274.
- Lethaby, A., Ayeleke, R.O. and Roberts, H. (2016) ‘Local oestrogen for vaginal atrophy in postmenopausal women’, Cochrane Database of Systematic Reviews, CD001500.
- Logan, S. et al. (2023) ‘Menopausal symptoms in midlife Singaporean women: prevalence rates and associated factors from the Integrated Women’s Health Programme (IWHP)’, Maturitas, 178, 107853.
- The Menopause Society (2020) ‘The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society’, Menopause, 27(9), pp. 976–992.
- National Institute for Health and Care Excellence (2015) Menopause: identification and management (NG23). London: NICE.
Salari, N. et al. (2023) ‘Global prevalence of sexual dysfunction in obese and overweight women: a systematic review and meta-analysis’, BMC Women’s Health, 23, 375. - Vieira-Potter, V.J. et al. (2025) ‘Health of adipose tissue: oestrogen matters’, Nature Reviews Endocrinology. DOI: 10.1038/s41574-025-01180-2. [volume and pages pending print issue]
- Visvabharathy, V. et al. (2025) ‘Anorgasmia following initiation of GLP-1 agonist’, Sexual Medicine, 13(3), qfaf047.